Ovarian cancer currently ranks fifth in cancer mortalities
Among women and is the leading cause of death from gynecologicalmalignancies. The conventional mode of therapy for this cancer consists of cytoreductive surgery, followed by adjuvant platinum/taxane-based chemotherapy [2]. However, while most ovarian cancer patients exhibit initial sensitivity to chemotherapy, over 70%